Skip to main content

GLYCOPYRROLATE

NDC 15955-305 · Alembic Labs LLC

Generic nameGLYCOPYRROLATE
Dosage formTABLET
RouteORAL
Active ingredient(s)GLYCOPYRROLATE
Strength1 mg/1
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA]
Marketing categoryANDA

Packages

15955-305-01 — 100 TABLET in 1 BOTTLE, PLASTIC (15955-305-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0781-3827 — Glycopyrrolate, 0781-3829 — Glycopyrrolate, 0781-3831 — Glycopyrrolate, 0904-6709 — Glycopyrrolate, 10122-120 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 10122-121 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 10122-460 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 10122-590 — beclomethasone dipropionate/formoterol fumarate/glycopyrrolate, 13107-014 — GLYCOPYRROLATE, 13107-015 — GLYCOPYRROLATE, 15955-318 — GLYCOPYRROLATE, 16571-743 — Glycopyrrolate, 16571-744 — Glycopyrrolate, 16729-471 — glycopyrrolate, 16729-472 — glycopyrrolate, 16729-473 — glycopyrrolate, 16729-474 — glycopyrrolate, 17856-1016 — Glycopyrrolate, 23155-606 — Glycopyrrolate, 23155-607 — Glycopyrrolate, +177 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels